Pillstats
Rx only · Patch · Transdermal

Levonorgestrel/Ethinyl Estradiol

Brands: Twirla · Ethinyl Estradiol + Levonorgestrel

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US1 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCG03CA01
RxCUI (US)4124
US makers1 labelers
Packages2
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$19.32$38.65$57.97$77.30Jan 2026Jun 2026Jul 2026
$66.852
Latest avg · Jul 22, 2026
-1%
Since Jan 1, 2026
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

9.2K18K28K37K2025 Q12025 Q22025 Q32025 Q42026 Q1
32K
Rx · 2026 Q1
180K
Units dispensed
+22%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Agile Therapeutics, Inc.unknown2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.